Drug profile · INN
leniolisib phosphate
JOENJA
- US status
- approved
- Patents linked
- 0
- News articles
- 0
Quick answer
leniolisib phosphate (JOENJA) is an FDA-listed pharmaceutical active ingredient. Route of administration: oral. Current US regulatory status: approved.
Key facts
INN leniolisib phosphate
Brand JOENJA
Route ORAL
Formulation TABLET
Frequently asked questions
What is leniolisib phosphate?
leniolisib phosphate (JOENJA) is an FDA-listed pharmaceutical active ingredient. Route of administration: oral. Current US regulatory status: approved.
What is the brand name for leniolisib phosphate?
JOENJA is a marketed brand name for leniolisib phosphate. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of leniolisib phosphate?
leniolisib phosphate has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.